If this was done back in the beginning of July bas
Post# of 36513
![](/assets/46931549/no_avatar_available_thumb.jpg)
So, Ii-Key is going to be protected for a much longer time; I can address the clinical trial questions, we're filing the IND by the end of June--the first day of July is the latest that we can possibly do it as far as I’m concerned on my internal timeline, anyway --and we expect to be able to initiate our Phase 1 trial with 159 patients targeted based upon the FDA's approval of the protocol; they have it, we submitted that protocol to them.
And it's a very complex and complicated protocol that PPD helped us put together,..”
Read More: https://investorshangout.com/post/view?id=620...z733s9QvEv
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)